Bentham Science publishes definitive guide on zebrafish in pharmacological research
Book Announcement
Updates every hour. Last Updated: 13-Jan-2026 15:12 ET (13-Jan-2026 20:12 GMT/UTC)
Bentham Science announces the release of an essential reference for researchers, educators, and industry professionals engaged in drug discovery and experimental pharmacology. Zebrafish Models for Experimental Pharmacology: A Handbook presents a clear, practical, and methodologically rich approach to harnessing the Zebrafish as a powerful model organism in biomedical research.
Gastric cancer that metastasizes to the peritoneum, or the lining of the abdominal cavity, has a very poor prognosis and is challenging to treat. Now, a group of researchers has developed mRNA-based vaccines that can target tumor-specific ‘neoantigens.’ In combination with anti-PD1 therapy, these vaccines show high antitumor efficacy against gastric cancer with peritoneal metastasis. This approach can potentially be expanded in order to develop ‘personalized’ cancer vaccines for complicated cancer cases.
Inhibiting a specific gene, MET, in combination with standard chemotherapy and immunotherapy, enhances treatment efficacy and limits tumor growth in small cell lung cancer (SCLC). The study, led by the Hospital del Mar Research Institute, analyzed the effect of MET inhibition in mouse models and studied gene expression in patient tumor samples. The results are published in Cell Reports Medicine. Researchers aim to pursue this line of research with a clinical trial involving patients.
A new systematic review of 172 studies including data from over 12 million adolescents across 166 countries reveals that while cross-national adolescent mental health research including low- and middle-income countries has expanded significantly, large gaps remain in global representation.
The University of Copenhagen is excited to announce Human Longevity, Inc. as Tier 1 Sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 25 - August 29, 2025 on-site at the Ceremonial Hall, University of Copenhagen, and online.
The German Research Foundation (DFG) is funding LMU scientist Anne-Laure Boulesteix: How can we improve research on statistical methods, asks the biostatistician, and thereby also improve their use?